SG/CALL/MERCK & CO./128/0.1/21.06.24 Share Price

Warrant

DE000SQ3S9D4

Delayed Deutsche Boerse AG 03:53:11 12/06/2024 pm IST
0.4 EUR -2.44% Intraday chart for SG/CALL/MERCK & CO./128/0.1/21.06.24
Current month+156.25%
1 month-12.77%
Date Price Change
12/24/12 0.4 -2.44%
11/24/11 0.41 +2.50%
10/24/10 0.4 +17.65%
07/24/07 0.34 0.00%
06/24/06 0.34 +9.68%

Delayed Quote Deutsche Boerse AG

Last update June 12, 2024 at 03:53 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SQ3S9D
ISINDE000SQ3S9D4
Date issued 03/11/2022
Strike 128 $
Maturity 21/06/2024 (10 Days)
Parity 10 : 1
Emission price 0.54
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.97
Lowest since issue 0.063
Spread 0.05
Spread %11.11%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.8 USD
Average target price
142.7 USD
Spread / Average Target
+8.22%
Consensus